David Christian Ward, Ph.D.

Affiliations: 
Genetics, Molecular Biophysics and Biochemistry Yale University, New Haven, CT 
Area:
Nucleotide chemistry; virology; genome organization
Google:
"David C. Ward"
Bio:

Developed method for non-radioactive labeling of nucleic acids (biotin-dUTP); Elected to National Academy of Science

Mean distance: 9.22
 
SNBCP

Parents

Sign in to add mentor
Edward Reich grad student 1969 Yale

Children

Sign in to add trainee
Michael J. Difilippantonio research assistant 1990-1992 Yale School of Medicine (Neurotree)
Matthew W. State grad student 2001 Yale (Neurotree)
Thomas Ried post-doc 1990-1992 Yale
A. Gregory Matera post-doc 1990-1993 Yale
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Leung EL, Luo LX, Li Y, et al. (2019) Identification of a new inhibitor of KRAS-PDEδ interaction targeting KRAS mutant non-small cell lung cancer. International Journal of Cancer
Leung ELH, Luo LX, Liu ZQ, et al. (2018) Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity. Cell Death & Disease. 9: 216
Torres AR, Sweeten TL, Johnson RC, et al. (2016) Common Genetic Variants Found in HLA and KIR Immune Genes in Autism Spectrum Disorder. Frontiers in Neuroscience. 10: 463
Simon LM, Ward DC. (2014) Preparing for events for physically challenged athletes. Current Sports Medicine Reports. 13: 163-8
Torres AR, Westover JB, Gibbons C, et al. (2012) Activating killer-cell immunoglobulin-like receptors (KIR) and their cognate HLA ligands are significantly increased in autism. Brain, Behavior, and Immunity. 26: 1122-7
Xu D, O TM, Shartava A, et al. (2011) Isolation, characterization, and in vitro propagation of infantile hemangioma stem cells and an in vivo mouse model. Journal of Hematology & Oncology. 4: 54
Wang J, Lu F, Ren Q, et al. (2011) Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties. Cancer Research. 71: 7238-49
Gonzales JC, Fink LM, Goodman OB, et al. (2011) Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer. Clinical Genitourinary Cancer. 9: 39-45
Goodman OB, Symanowski JT, Loudyi A, et al. (2011) Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer. Clinical Genitourinary Cancer. 9: 31-8
Alipio ZA, Jones N, Liao W, et al. (2011) Epithelial to mesenchymal transition (EMT) induced by bleomycin or TFG(b1)/EGF in murine induced pluripotent stem cell-derived alveolar Type II-like cells. Differentiation; Research in Biological Diversity. 82: 89-98
See more...